Gabelli Funds’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.3M Hold
127,317
0.21% 136
2026
Q1
$31.1M Sell
127,317
-4,997
-4% -$1.16M 0.21% 132
2025
Q4
$27.4M Sell
132,314
-29,436
-18% -$5.82M 0.19% 145
2025
Q3
$30M Sell
161,750
-34,135
-17% -$5.85M 0.2% 123
2025
Q2
$29.9M Hold
195,885
0.21% 115
2025
Q1
$32.5M Buy
195,885
+400
+0.2% +$62.6K 0.25% 102
2024
Q4
$28.3M Buy
195,485
+2,450
+1% +$380K 0.21% 127
2024
Q3
$31.3M Sell
193,035
-1,600
-0.8% -$255K 0.23% 118
2024
Q2
$28.4M Sell
194,635
-1,850
-0.9% -$275K 0.22% 120
2024
Q1
$31.1M Sell
196,485
-4,600
-2% -$732K 0.23% 111
2023
Q4
$31.5M Buy
201,085
+2,550
+1% +$391K 0.24% 113
2023
Q3
$30.9M Sell
198,535
-1,465
-0.7% -$242K 0.25% 109
2023
Q2
$33.1M Buy
200,000
+5,050
+3% +$815K 0.25% 105
2023
Q1
$30.2M Buy
194,950
+1,500
+0.8% +$242K 0.23% 117
2022
Q4
$34.2M Sell
193,450
-5,600
-3% -$967K 0.27% 97
2022
Q3
$32.5M Sell
199,050
-1,167
-0.6% -$197K 0.27% 98
2022
Q2
$35.5M Sell
200,217
-1,550
-0.8% -$276K 0.27% 93
2022
Q1
$35.8M Sell
201,767
-12,150
-6% -$2.07M 0.23% 115
2021
Q4
$36.6M Buy
213,917
+100
+0% +$16.4K 0.23% 120
2021
Q3
$34.5M Sell
213,817
-5,545
-3% -$946K 0.23% 123
2021
Q2
$36.1M Sell
219,362
-5,359
-2% -$887K 0.23% 116
2021
Q1
$36.9M Buy
224,721
+6,971
+3% +$1.13M 0.25% 112
2020
Q4
$34.3M Sell
217,750
-500
-0.2% -$73.8K 0.24% 117
2020
Q3
$32.5M Sell
218,250
-400
-0.2% -$59.2K 0.25% 111
2020
Q2
$30.7M Sell
218,650
-1,250
-0.6% -$182K 0.25% 112
2020
Q1
$28.8M Sell
219,900
-800
-0.4% -$114K 0.26% 111
2019
Q4
$32.2M Sell
220,700
-34,500
-14% -$4.68M 0.21% 136
2019
Q3
$33M Sell
255,200
-2,500
-1% -$329K 0.22% 134
2019
Q2
$35.9M Sell
257,700
-17,500
-6% -$2.42M 0.23% 123
2019
Q1
$38.5M Sell
275,200
-20,000
-7% -$2.68M 0.24% 119
2018
Q4
$38.1M Sell
295,200
-39,400
-12% -$5.5M 0.26% 104
2018
Q3
$46.2M Sell
334,600
-15,200
-4% -$2.02M 0.27% 106
2018
Q2
$42.4M Sell
349,800
-12,800
-4% -$1.6M 0.25% 112
2018
Q1
$46.5M Sell
362,600
-30,000
-8% -$4.05M 0.28% 99
2017
Q4
$54.9M Sell
392,600
-67,700
-15% -$9.43M 0.32% 84
2017
Q3
$59.8M Sell
460,300
-38,600
-8% -$5.12M 0.34% 78
2017
Q2
$66M Sell
498,900
-20,400
-4% -$2.6M 0.39% 56
2017
Q1
$64.7M Buy
519,300
+5,700
+1% +$681K 0.38% 61
2016
Q4
$59.2M Sell
513,600
-27,300
-5% -$3.15M 0.35% 72
2016
Q3
$63.9M Sell
540,900
-43,500
-7% -$5.28M 0.38% 68
2016
Q2
$70.9M Sell
584,400
-75,600
-11% -$8.59M 0.42% 53
2016
Q1
$71.4M Sell
660,000
-34,500
-5% -$3.57M 0.43% 56
2015
Q4
$71.3M Sell
694,500
-11,000
-2% -$1.11M 0.43% 55
2015
Q3
$65.9M Buy
705,500
+34,000
+5% +$3.29M 0.39% 63
2015
Q2
$65.4M Sell
671,500
-26,500
-4% -$2.65M 0.34% 77
2015
Q1
$70.2M Buy
698,000
+3,500
+0.5% +$356K 0.36% 73
2014
Q4
$72.6M Sell
694,500
-3,000
-0.4% -$316K 0.35% 77
2014
Q3
$74.3M Sell
697,500
-24,500
-3% -$2.54M 0.38% 68
2014
Q2
$75.5M Sell
722,000
-5,000
-0.7% -$505K 0.37% 71
2014
Q1
$71.4M Buy
727,000
+12,000
+2% +$1.11M 0.37% 69
2013
Q4
$65.5M Sell
715,000
-4,000
-0.6% -$369K 0.35% 71
2013
Q3
$62.3M Hold
719,000
0.35% 75
2013
Q2
$61.7M Buy
+719,000
New +$61M 0.37% 67

Other funds holding JNJ

Gabelli Funds's JNJ Position: Q2 2026 in Review

Gabelli Funds held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 127,317 shares worth $32.3M. The position accounts for 0.21% of the portfolio, ranked #136.

Gabelli Funds first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $75.5M in Q2 2014. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gabelli Funds held 127,317 shares of Johnson & Johnson worth $32.3M as of Q2 2026.
  • Gabelli Funds left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.21% of Gabelli Funds's portfolio in Q2 2026, its #136 holding.
  • Gabelli Funds first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Gabelli Funds's Johnson & Johnson position peaked at $75.5M in Q2 2014.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.